DNA repair-deficient Xpa and Xpa/p53+/- knock-out mice: nature of the models.
about
Nuclear bud formation: a novel manifestation of Zidovudine genotoxicityp53 haploinsufficiency profoundly accelerates the onset of tongue tumors in mice lacking the xeroderma pigmentosum group A gene.Assessment of carcinogenicity of di(2-ethylhexyl)phthalate in a short-term assay using Xpa-/- and Xpa-/-/p53+/- mice.Evaluation of the Xpa-deficient transgenic mouse model for short-term carcinogenicity testing: 9-month studies with haloperidol, reserpine, phenacetin, and D-mannitol.Diethylstilbestrol (DES): carcinogenic potential in Xpa-/-, Xpa-/- / p53+/-, and wild-type mice during 9 months' dietary exposure.DNA repair-deficient Xpa/p53 knockout mice are sensitive to the non-genotoxic carcinogen cyclosporine A: escape of initiated cells from immunosurveillance?Role of nucleotide excision repair and p53 in zidovudine (AZT)-induced centrosomal deregulation.TP53 mutations induced by BPDE in Xpa-WT and Xpa-Null human TP53 knock-in (Hupki) mouse embryo fibroblasts.The use of genetically modified mice in cancer risk assessment: challenges and limitations.Use of transgenic mice in carcinogenicity hazard assessment.Downregulated XPA promotes carcinogenesis of bladder cancer via impairment of DNA repair.Silibinin enhances the repair of ultraviolet B-induced DNA damage by activating p53-dependent nucleotide excision repair mechanism in human dermal fibroblastsIssues in the design and interpretation of chronic toxicity and carcinogenicity studies in rodents: approaches to dose selection.An industry perspective on the utility of short-term carcinogenicity testing in transgenic mice in pharmaceutical development.Critical review of preclinical approaches to evaluate the potential of immunosuppressive drugs to influence human neoplasia.K14-EGFP-miR-31 transgenic mice have high susceptibility to chemical-induced squamous cell tumorigenesis that is associating with Ku80 repression.DICER- and MMSET-catalyzed H4K20me2 recruits the nucleotide excision repair factor XPA to DNA damage sites.Association of XPA polymorphism with breast cancer risk: A meta-analysis.
P2860
Q30494840-F5016460-C065-478A-A515-09EACC7DBE0DQ31017206-C5E40D1F-5991-456E-A442-C8784B3BA1F9Q31048253-CD3DE629-6981-41F7-BE2E-2A73489A3A40Q33203784-7CD0E3DC-923E-4907-A45F-DD64D67F1A8FQ33223773-432C886A-20DA-4FAD-9614-44CE7B1FF0C3Q33399015-35A185F8-CE5E-4CA0-BD29-8559829E08F2Q35215308-45EE0DD3-125F-4F6A-AED0-CD4285E54401Q35595867-94CD0A08-CBCF-4833-9766-A8C7293C17FDQ35688431-406AD475-0289-49AE-B670-D511612AD8FBQ35812504-80FBFF14-1725-4B0E-9934-BDCE21E08C89Q36286616-84836013-C5B7-4F51-AB47-08C982F962F8Q36545426-8CCDB2F0-F3B4-4816-873E-24869A3932F7Q36980449-6760AB5B-2191-444B-BC0E-CDF4EF24DEA0Q37628343-47E7945D-EA75-41AE-8467-2A8CB5EF071FQ37795414-31F5A143-1B7A-4454-8805-DA19A87B7B7CQ38969680-9AD63318-CCAD-40DF-BE2E-D064CDB83BE5Q48131232-85ADCCB4-833A-4A37-ABFB-1AA8FB5E4D4DQ55691604-E619480C-359D-440D-8FB6-7CC8C120315A
P2860
DNA repair-deficient Xpa and Xpa/p53+/- knock-out mice: nature of the models.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
DNA repair-deficient Xpa and Xpa/p53+/- knock-out mice: nature of the models.
@ast
DNA repair-deficient Xpa and Xpa/p53+/- knock-out mice: nature of the models.
@en
type
label
DNA repair-deficient Xpa and Xpa/p53+/- knock-out mice: nature of the models.
@ast
DNA repair-deficient Xpa and Xpa/p53+/- knock-out mice: nature of the models.
@en
prefLabel
DNA repair-deficient Xpa and Xpa/p53+/- knock-out mice: nature of the models.
@ast
DNA repair-deficient Xpa and Xpa/p53+/- knock-out mice: nature of the models.
@en
P2093
P1476
DNA repair-deficient Xpa and Xpa/p53+/- knock-out mice: nature of the models.
@en
P2093
A de Vries
C F van Kreijl
H van Steeg
J van Benthem
van Oostrom CTh
P304
P356
10.1080/019262301753178519
P407
P478
P577
2001-01-01T00:00:00Z